Europe’s drug regulator backed GSK Plc’s drug to treat severe asthma or a common nasal condition, in the first such recommendation globally for a medicine that is pegged to become a blockbuster.
www.bloomberg.com
#GSKs #Potential #Blockbuster #Asthma #Drug #European #Backing
US President Donald Trump’s de-escalation on tariffs offered a temporary reprieve to African businesses, some which initially considered abandoning the…
Mientras la ciudad se transforma en un destino turístico de lujo, los pequeños negocios en dificultades luchan por conservar el carácter…
S&P Global Ratings pushed back against claims of bias in assessing the creditworthiness of African governments, saying all receive equal…
